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Abstract 
Spina bifida, specifically myelomeningocele, is a debilitating neural tube defect that 
affects patients and families throughout the world.  Traditional management and 
treatment methods are described, followed by an explanation of why this is often 
inadequate in providing care for those in impoverished areas of the world, including 
many regions of Africa. Endoscopic third ventriculostomy is proposed as a promising 
alternative to traditional methods for treating hydrocephalus, an often associated 
condition, and the implementation of this treatment method in Africa is explored. In order 
to relieve Africa of the burden of spina bifida-related hydrocephalus and improve global 
management of spina bifida, it is imperative that the paucity of neurosurgeons in Africa 
be addressed and successful models for training be expanded. 
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A Closer Look at the Global Management of Spina Bifida: The Implementation of 
Endoscopic Third Ventriculostomy in the Treatment of Spina Bifida-Related 
Hydrocephalus in Africa 
What Is Spina Bifida? 
Spina bifida is a disease that results from failure of the neural tube to develop 
correctly in an embryo. This causes improper development of the spinal column, which 
can have varying levels of severity depending on the type and location of the lesion. 
When the neural tube develops normally, the neural plate edges fold toward the midline 
where they eventually meet and fuse together, giving rising to the neural tube; bone and 
muscle then create a barrier that protects the neural plate as it develops into the spinal 
cord (Northrup and Volcik, 2000). When a section of the neural plate does not fuse 
together, however, the growth of bone and muscle over that open segment of the 
developing spinal column is impeded, creating the “hole” or lesion that is characteristic 
of spina bifida (Northrup and Volcik, 2000). This disease affects about 3.1 children and 
adolescents per 10, 000 in the United States, which means more than 24, 000 children and 
adolescents are living with this disease in the United States alone; overall, spina bifida is 
slightly more prevalent in females than males (Shin et al., 2010).  
Types of Spina Bifida 
The mildest and most common form of spina bifida is known as spina bifida 
occulta (“hidden”). This occurs when development of the vertebrae is incomplete, but the 
skin covering the defect is still intact (Castillo and Oppenheimer, 2016).  Though there is 
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a gap in at least one of the vertebral arches, the spinal cord and meninges do not protrude 
through this space but rather stay inside the vertebral canal (Northrup and Volcik, 2000).  
This may present itself as a small sinus between two vertebrae where they did not join 
correctly, and a person with this form of spina bifida may have a small dimple, hairy 
patch, or birth mark over the place where they have the abnormality (Northrup and 
Volcik, 2000).   If only one vertebra is abnormal, there are usually no neurologic or 
clinical symptoms; this form is even considered a normal variation in the population 
because it occurs in the lumbar or sacral region of about 10% of people who have no 
other health problems (Northrup and Volcik, 2000).  However, bowel, bladder, and motor 
problems may arise if more than one vertebra is involved (Northrup and Volcik, 2000).  
 The other forms of spina bifida fall under the classification of spina bifida cystica, 
which is the category this report will mainly focus on. These forms are more severe and 
involve a cerebrospinal fluid-filled cystic sac on the spinal column into which the 
meninges and/or spinal cord protrude. When only the meninges extend into this sac and 
the spinal cord and root are still in the proper position, it is known as the meningocele 
form of spina bifida (Northrup and Volcik, 2000).  Although this type of lesion does not 
involve nerves, it can still be accompanied by hydrocephalus and abnormalities of the 
central nervous system (Castillo and Oppenheimer, 2016). However, when both the 
meninges and spinal cord protrude into this sac, it falls under the myelomeningocele 
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category (see Figure 1). 
 
Figure 1. Anatomy of Spina Bifida. 
Spina bifida is a disease characterized by improper development of the spinal column due 
to a defect in neural tube development. There are varying severities of the condition 
depending on the type and location of the lesion. Shown above is the myelomeningocele 
form, in which the spinal cord and nerves protrude through an opening in the spinal 
column. (Figure reprinted from Pace, B. and Lymn, C.: JAMA Patient Page: Spina 
Bifida. JAMA 285(23):3050, 2001. DOI:10.1001/jama.285.23.3050, with permission 
from the American Medical Association.) 
 
This form is the most severe and is more common than meningocele defects 
(Northrup and Volcik, 2000).  The level of the lesion on the spine also affects the severity 
of this disease.  In general, the higher the lesion the more severe the symptoms due to 
proximity to the brain; with myelomeningoceles, there is usually paralysis from the 
location of the lesion down, along with urinary and fecal incontinence, skin anesthesia, 
and hip, knee, and feet abnormalities (Northrup and Volcik, 2000).  
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Spina Bifida Etiology 
 The exact etiology of neural tube defects in general is not perfectly understood, 
but there are several factors that appear to contribute to the formation of spina bifida.  
One of the strongest risk factors that has been established for spina bifida is having a 
family history of spina bifida or anencephaly, another type of neural tube defect that 
involves the brain itself (Mitchel et al., 2004). When a couple has already had a child 
with spina bifida, the risk for spina bifida in subsequent siblings is higher than in the 
general population, ranging from 3% to 8% (Mitchel et al., 2004).   
It has also been shown that not taking in enough folate before and during early 
pregnancy leads to increased risk of the fetus having spina bifida. In fact, the United 
States Public Health Service recommends that all women in the United States who are 
capable of having children take 0.4 mg of folic acid a day in order to reduce the risk of 
having a child affected by spina bifida or another neural tube defect (CDC, 2004). 
Research using vitamin supplements has demonstrated that not consuming adequate folic 
acid increases the risk of the child having spina bifida by two-fold to eight-fold (Mitchel 
et al., 2004). Though the mechanism explaining this association has not been determined 
exactly, it is known that folate plays a part in two metabolic pathways that are very 
important to the developing embryo; one pathway contributes to nucleic acid synthesis, 
and the other is involved in a variety of other methylation reactions (Mitchel et al., 2004).  
The concentration of homocysteine levels can also increase when folate metabolism is 
disrupted, which in some animal models is known to be teratogenic to the neural tube 
(Mitchel et al., 2004).  Other known teratogens are anticonvulsant drugs such as valproic 
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acid and carbamazepine, which are associated with an increased risk in fetal spina bifida 
when taken by the mother (Hernández-Díaz et al., 2001).  It is estimated that up to 1% to 
2% of fetuses who are exposed to valproic acid end up developing a neural tube defect 
(Koren and Kennedy, 1999). The mechanism by which these drugs affect the 
development of spina bifida is also unknown, though there are several theories, including 
that it affects the metabolism of folate (Mitchel et al., 2004). Some other factors include a 
genetic predisposition for the disease, whether mothers have pregestational diabetes 
(increased risk when mothers do have it), and the presence of malformation syndromes 
due to chromosomal abnormalities and single gene disorders (Castillo and Oppenheimer, 
2016).   
Diagnosis of Spina Bifida 
 Many neural tube defects are able to be detected before the baby is born. A 
screening test can be performed between the 16th and 18th week of gestation in which the 
alpha-fetoprotein is measured in the maternal serum; increased levels of this protein can 
be an indicator of the presence of a neural tube defect (Castillo and Oppenheimer, 2016). 
However, this test is not highly specific or sensitive and is therefore not conclusive alone 
(Cameron and Moran, 2009). Following this screening test, amniocentesis may be 
performed in which a sample of the amniotic fluid is obtained and the fetal DNA can be 
analyzed for genetic abnormalities (Nicolaides et al., 1986). However, this option carries 
a small risk of miscarriage, and a less invasive alternative to examine those with a high 
serum alpha-fetoprotein is to perform a detailed ultrasound examination (Nicolaides et 
al., 1986). The ultrasound is capable of showing the U-shaped open neural arch and any 
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myelocele or myelomeningocele that may be present (Nicolaides et al., 1986). These 
ultrasound examinations can be as sensitive as 96% and as specific as 99.9% when the 
spine is examined by a very skilled ultrasonographer (Nicolaides et al., 1986). There are 
several cranial and cerebellar signs that are telling and easy to identify in determining the 
presence of open spina bifida that helps improve the accuracy of these ultrasound 
examinations (Nicolaides et al., 1986). The use of ultrasound has for the most part 
surpassed the use of alpha-fetoprotein in screening for neural tube defects since it has 
such a higher level of specificity (Cameron and Moran, 2009).  Some centers also use 
MRI to detect spina bifida prenatally; this can help estimate the level of the lesion, as 
well as analyze intracranial pathology and other potential structural abnormalities 
(Castillo and Oppenheimer, 2016).  Even if spina bifida is not detected before birth, it is 
usually evident upon physical examination at birth as there is often a corresponding 
irregularity on the cutaneous level (Castillo and Oppenheimer, 2016).  
Spina Bifida Management 
Once a baby with spina bifida is born, a multidisciplinary team is essential in 
providing the appropriate care and treatment required. The first issue that must be dealt 
with is the lesion itself. Novel surgical techniques have actually made it possible to 
address this while the baby is still in the womb.  One study done by Olutoye and Adzick 
reported success in repairing a large myelomeningocele in a fetus at 23 weeks with open 
fetal surgical intervention (Olutoye and Adzick, 1999). For myelomeningoceles, this in 
utero surgery removes the cystic membrane of the lesion, disconnects attachments of the 
meninges, and allows the spinal cord to fall into its proper place in the spinal canal 
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(Northrup and Volcik, 2000). An acellular dermal graft is put between the skin and spinal 
cord to prevent it from tethering, and then the skin is closed up over the area (Northrup 
and Volcik, 2000). Research suggests that if this procedure is performed early enough 
(before the 24th week of gestation ends), the young fetus’s regenerative properties will be 
able to help heal the wound and potentially prevent damage to the spinal cord later on in 
pregnancy, as well as possibly resolving some secondary conditions associated with spina 
bifida (Olutoye and Adzick, 1999).  However, traditionally the lesion is repaired as soon 
as possible after birth, usually within the first 24 to 48 hours (Philips et al., 2017). Further 
tests can then be performed to determine the extent of secondary conditions.  
 Urological management.  Urological management is another important facet of 
care for spina bifida patients.  The nerves of the bladder originate in the thoracic, lumbar, 
and sacral spinal cord, so bladder function in spina bifida patients is almost always 
affected (Castillo and Oppenheimer, 2016).  The level of the lesion is not always a 
precise indicator of bladder function, but generally the higher level lesions cause the 
bladder to retain urine, while lower level lesions cause it to leak urine (Castillo and 
Oppenheimer, 2016).  When the bladder does not empty properly, there is an increased 
risk for urinary tract infections, as well as complications with and damage to the kidneys 
due to the high pressures from poor emptying (Phillips et al., 2017).  Bladder 
management involves clean intermittent catheterization, as well as medication to help 
control bladder spasms (Phillips et al., 2017).  For babies the goal of management is 
simply to maintain normal bladder pressure and keep the kidneys safe, but as children 
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grow older social continence is also a goal and can usually be achieved by 
catheterization, although surgery is sometimes necessary (Phillips et al., 2017).   
 Bowel management.  Because the sacral nerves also innervate the rectal 
sphincter, most children with myelomeningocele (about 90%) will have a neurogenic 
bowel that will require management (Phillips et al,. 2017).  Spina bifida patients with a 
lesion at the thoracic level often face difficulty in bearing down, whereas patients with 
sacral level spina bifida often have a hard time attaining proper stool consistency; the 
goal of bowel management is for a patient to be able to empty their bowel of soft, formed 
stools regularly and consistently each day (Castillo and Oppenheimer, 2016). Bowel 
emptying techniques are an essential tool in management and include rectal stimulation, 
suppositories, behavioral training, and enemas; surgical intervention may be required if 
the patient is not able to achieve fecal continence with these techniques (Castillo and 
Oppenheimer, 2016).  
 Orthopedic management.  Spina bifida patients will also require orthopedic 
management. Ambulation is strongly dependent on the level of sensorimotor function, 
which is the main factor in determining lumbar and sacral lesions, and independent 
mobility is probable in almost all cases of these lesions (Castillo and Oppenheimer, 
2016).  However, for lesions above L2, independent mobility is not likely and a 
wheelchair will probably be necessary (Castillo and Oppenheimer, 2016). Unfortunately, 
as children age their ability to ambulate can deteriorate as weight and orthopedic 
deformity increase, making walking more difficult, and a wheelchair often becomes a 
more efficient option at that point (Castillo and Oppenheimer, 2016).  Orthopedic 
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management involves the prevention or correction of deformities in order to help patients 
achieve the highest level of mobility and independence that is realistic for them 
(Thomson and Segal, 2010).  A wide range of abnormalities, including a tethered cord, 
hip disorders, knee, foot, or ankle deformities or problems, scoliosis, and kyphosis, may 
need to be addressed (Thomson and Segal, 2010).  Physical therapy from an early age is 
essential to achieving optimal motor function, and should aim to normalize experiences, 
help improve posture for sitting or standing, manage orthotics, and keep the skin from 
breaking down (Castillo and Oppenheimer, 2016). Orthotics can be helpful in preventing 
contracture, as well as encouraging independent mobility, and walkers, braces, standers, 
and parapodiums may also be used to help with support and mobility (Castillo and 
Oppenheimer, 2016). 
 Developmental and cognitive management.  There is a wide range of 
developmental outcomes for children with spina bifida. In general, a higher level lesion is 
associated with more severe abnormalities of brain development, which in turn result in 
more serious neurobehavioral impairments (Fletcher et al., 2005).  Children with spina 
bifida often have specific learning disabilities, but a majority of them, about 80%, still 
have intelligence within the normal range (Castillo and Oppenheimer, 2016). They are 
generally stronger in language, such as reading and spelling, and weaker in perceptual, 
motor, and math skills (Castillo and Oppenheimer, 2016).  Routine neuropsychological 
and psycho-educational evaluations are helpful in identifying learning issues and can aid 
in developing an appropriate educational plan for the child with spina bifida (Castillo and 
Oppenheimer, 2016).  
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Neurosurgical management.  Neurosurgical management is a very important 
aspect of providing care for spina bifida patients. Children with spina bifida usually also 
have a Chiari II malformation, but this is only addressed with surgery when it is 
symptomatic enough, which only occurs in about 15-35% of cases (Castillo and 
Oppenheimer, 2016). A Chiari II malformation usually forms because the fourth ventricle 
did not develop sufficiently, creating a small posterior fossa which can cause the brain to 
be displaced caudally with the cerebellum and brainstem extending through the foramen 
magnum (Phillips et al., 2017). Surgical intervention may be needed if patients cannot 
regulate their breathing, lose the normal function of their vocal cords, have a hard time 
swallowing, or are weak in their arm or hand (Phillips et al., 2017).   
Another neurological problem patients with spina bifida often face is a tethered 
spinal cord. This happens when the end of the spinal cord is tethered to the spine by scar 
tissue, creating tension as the child grows and stretches (Phillips et al., 2017).  Almost all 
children with a repaired myelomeningocele will have this, but it is usually asymptomatic 
and left untreated because it will often just re-tether (Castillo and Oppenheimer, 2016). 
Nevertheless, if a patient experiences back or leg pain, leg spasms, weakness, 
deterioration in gait or sensation, or increased constipation or urological irregularities, an 
untethering procedure should be considered (Phillips et al., 2017).  
In addition to these issues, the initial closing of the lesion in the spine often 
disrupts the pathway of the cerebrospinal fluid, creating a condition known as 
hydrocephalus in which the cerebrospinal fluid accumulates in the ventricles of the brain 
and causes them to swell (see Figure 2). At least 70-85% of children who have 
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hydrocephalus related to spina bifida, if not more, end up needing to have a shunt placed 
in order to maintain normal intracranial pressure (Philips et al., 2017).   
 
Figure 2. Anatomy of Hydrocephalus.  
Children with spina bifida often develop hydrocephalus upon closure of their spinal 
lesion. Hydrocephalus is characterized by an accumulation of cerebrospinal fluid in the 
ventricles of the brain due to disruption of the cerebrospinal fluid pathway. This can be 
seen in their enlargement compared to the ventricles of a normal brain. This buildup of 
cerebrospinal fluid then results in brain compression due to the pressure exerted by the 
swollen ventricles. (Figure created using BioDigital Human software.) 
 
Global Management of Spina Bifida 
Clearly, a considerable amount of skill and effort are required when caring for 
patients who have spina bifida and providing the treatment and management they need to 
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live a quality life. Unfortunately, this care can be difficult to deliver in places of the 
world that are lacking in resources, such as many impoverished regions of Africa. 
Though the exact incidence of this disease is not known for these regions, most likely it is 
as high as that reported for any other area of the world (Warf, 2011). This means that at 
least one child in every 1, 000 live births is affected with myelomeningocele; still, the 
number of individuals affected is probably higher compared to developed countries due 
to higher birth rates (Warf, 2011). Of the children affected by neural tube defects, about 
80-90% develop the associated condition hydrocephalus (Warf et al., 2008).  As 
mentioned previously, the traditional treatment for this condition is the placement of a 
ventriculoperitoneal shunt. However, this treatment brings with it an array of challenges, 
especially in poverty-stricken contexts.  
Challenges with Traditional Treatment 
Shunts are known to have a high rate of failure and complications, and numerous 
studies have demonstrated this unfortunate phenomenon. In a study by Dakurah and his 
colleagues, 37 of their patients who received shunts developed complications associated 
with the shunt (Dakurah et al., 2016).  An 86% shunt failure rate was reported for the 
spina bifida population of a study by Steinbok and his coauthors (Steinbok et al., 1992), 
while another study by Tuli and his colleagues yielded a 64% failure rate of the spina 
bifida population (Tuli et al., 2003). 
 Numerous problems can occur when a shunt is placed. The most common 
complication is the development of a shunt infection; according to Idowu and his 
colleagues, a shunt infection can lead to a higher risk of seizure disorder, as well as 
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decreased intellectual performance and an increase in mortality rate long-term (Idowu et 
al., 2009). They also point out that these infections are potentially fatal, especially if the 
child is brought in late for treatment, which is often in the case in this context (Idowu et 
al., 2009). Another potential complication is migration of the shunt, which requires 
another surgery to correct its placement; over time shunts can also become leaky, 
obstructed, or disconnected (Dakurah et al., 2016). These all contribute to the high failure 
and complication rates of shunts, which in turn accounts for the high likelihood of 
subsequent revisional surgeries. In adult patients with myelomeningocele, a life-time 
dependence on a shunt has even been associated with decreased survival (Davis et al., 
2005).  
In developed countries, these complications and failures can be dealt with and 
tolerated because emergency neurosurgical care facilities are more readily accessible. 
However, this is not the case in many regions of Africa where hospitals are few and far 
between and poverty and poor infrastructure also contribute to lack of access (Warf, 
2011). On top of all this, children in developing countries are often malnourished and 
therefore already predisposed to infection (Laeke et al., 2017). This has prompted the 
search for a different approach to treating hydrocephalus, one that is more appropriate for 
less developed contexts.   
A Promising Alternative 
 What is ETV?  Endoscopic third ventriculostomy (ETV) is a surgical procedure 
that offers hope as an alternative to traditional shunt placement. In ETV, holes are made 
in the floor of the third ventricle of the brain to allow for the drainage of the accumulated 
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cerebrospinal fluid (CSF) into the normal CSF pathway for reabsorption into the body 
(see Figure 3).  
 
Figure 3. ETV location. 
ETV is a procedure in which holes are placed in the floor of the third ventricle, labeled 
above, allowing excess cerebrospinal fluid to be reabsorbed into the body by the normal 
CSF pathway. (Figure used with permission from website article: About Your 
Endoscopic Third Ventriculostomy (ETV) Surgery for Pediatric Patients. Memorial 
Sloan Kettering Cancer Center, 2014.) 
 
Surgical technique.  Benjamin Warf, a leading surgeon in the advancement of 
ETV in Africa, describes his procedure for performing ETV in several of his articles. 
Patients were prepared with anesthesia and by placement in the supine position with their 
heads turned to the left (Warf and Campbell, 2008).  This position is the same used when 
placing a right frontal ventriculoperitoneal shunt, allowing for a quick transition to the 
placement of a shunt in the case of ETV failure during the procedure (Warf and 
©2014, Memorial Sloan Kettering Cancer Center 
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Campbell, 2008). The incision for entry was made in the right lateral corner of the 
anterior fontanel; after that, the dura was opened and the cortical surface was coagulated 
and penetrated, allowing for the insertion of the endoscope at the right frontal horn where 
it could then be guided into the third ventricle (Warf and Campbell, 2008). The 
endoscope could then be used to view the aqueduct and floor of the ventricle so that the 
site for the ETV could be decided (Warf and Campbell, 2008). Then a Bugby wire was 
used to break through the ventricular floor, while avoiding the use of electrocautery so as 
not to harm the basilar artery, until the endoscope could enter the prepontine cistern and 
proper CSF flow was observed (Warf and Campbell, 2008).  
Choroid plexus cauterization.  The choroid plexus is a collection of cells that 
produces cerebrospinal fluid in the ventricles of the brain. Cauterizing this in conjunction 
with performance of ETV has been shown to improve the success rate of ETV treatment, 
especially in certain etiologies of hydrocephalus. In this procedure, cauterization is 
performed on the choroid plexus with the Bugby wire monopolar electrocautery starting 
at the right foramen of Monro and continuing back into the atrium; once this is done, the 
endoscope was maneuvered into the right temporal horn to reach the rest of the choroid 
plexus (Warf and Campbell, 2008). This same procedure was then performed in the right 
ventricle. This leaves it more shriveled and unable to continue producing excess spinal 
fluid that could contribute to the fluid build-up in hydrocephalus (see Figure 4). 
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Figure 4. Choroid plexus before and after cauterization (Warf, 2005). 
The normal anatomy of the choroid plexus can be seen in the image on the left. After it is 
cauterized by the Bugby wire, it can be seen white and shriveled in the image on the 
right, rendering it unable to produce excess cerebral spinal fluid. (Figure used with 
permission from Warf BC: Comparison of endoscopic third ventriculostomy alone and 
combined with choroid plexus cauterization in infants younger than 1 year of age: a 
prospective study in 550 African children. J Neurosurg Pediatr 103:475–481, 2005. 
DOI: 10.3171/ped.2005.103.6.0475.) 
 
Benefits of ETV.  One very important benefit of ETV is that it has few 
complications. Contrast this with the placement of a ventriculoperitoneal shunt, which 
has a very high complication rate as discussed previously. Ojo and his coauthors point 
out the range of 23% to 25.8% for the complication rate of ventriculoperitoneal shunts, 
compared to a 6 to 8% complication rate with ETV (Ojo et al., 2016). Because no 
hardware is placed in the brain with ETV, it cannot be displaced over time, develop leaks, 
or become disconnected; the majority of the difficulties associated with shunts are not 
obstacles with ETV. Sometimes surgery needs to be performed again, but this happens on 
a rarer occasion than do shunt revisions (Warf, 2013). Complications with ETV have 
been shown to usually occur within 6 months after surgery and are easily discernible 
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(Warf, 2013). This makes it easy to resolve them before they can cause severe damage. 
Due to the fact that it has a lower complication rate, this type of surgery also requires 
minimum follow-up. This is very important because in many regions of Africa, it is very 
difficult to reach places where one can receive medical attention. Many times, families 
need to travel long distances to a medical facility, but this can be dangerous due to 
regions of poor infrastructure; poverty also inhibits traveling (Warf and Campbell, 2008). 
When a child has hydrocephalus, treatment is urgent. But many times, families cannot 
reach a medical facility in time. It is therefore a great advantage that this surgery has a 
low complication rate.  
Another significant benefit of ETV is that it has a high success rate. In a study by 
Ojo and his colleagues, they found that this surgery has a success rate of 73% in their 
Nigerian setting (Ojo et al., 2015).  This is only one example of studies that have 
demonstrated the high success rate for this procedure. In the beginning, there had been 
some concern that this procedure was not very successful in patients with hydrocephalus 
of certain etiologies, like myelomeningocele. However, the procedure choroid plexus 
cauterization described previously is a procedure that can be paired with ETV and has 
demonstrated better success rates for the majority of these etiologies. In a study by Warf 
and his colleagues, the success rate increased from 35 to 76% with the addition of 
choroid plexus cauterization in children with myelomeningocele (Warf et al., 2009). This 
discovery makes ETV a viable option for numerous children, giving it a high success rate 
in a wide range of etiologies.  
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Finally, ETV is a more cost effective procedure. Komolafe and his colleagues 
reported that 15.1 % of the families that need treatment for a child’s hydrocephalus left 
before surgery against the doctor’s advice due to financial limitations (Komolafe et al., 
2007). Therefore, the provision of economic treatment is crucial to the service of the 
African population. Shunts can be very expensive; many times it is therefore not an 
option for many poor families. Although less expensive shunts have been developed, they 
have other associated costs, especially if they cause repeated problems (Idowu et al., 
2009). Because ETV does not require the placement of hardware in the brain, this is not 
an expense for this type of procedure. This surgery is also a shorter procedure than the 
placement of a shunt, meaning several things. First of all, it means that this procedure 
requires a much shorter hospital stay. Furthermore, Idowu explains that an abbreviated 
procedure requires less anesthesia (Idowu et al., 2009). These factors reduce the expenses 
of the family considerably. Taking all this into consideration makes ETV very beneficial 
when it comes to treating hydrocephalus in a poor population.  
The Problem That Still Stands 
 Although ETV has advantages over shunt placement and is a promising 
alternative in low-resource settings for the management of hydrocephalus, it is still not a 
widespread treatment option in Africa. Neurosurgical care in Africa is greatly limited by 
a shortage of neurosurgeons and a lack of knowledge of neuroendoscopic management of 
hydrocephalus. To put things in perspective, there is one neurosurgeon for every 90, 000 
inhabitants in the United States; however, in East Africa (Uganda, Tanzania, and Kenya) 
it is estimated there is one neurosurgeon for every 10 million people (Burton, 2015).  It is 
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also estimated that sub-Saharan Africa, not including South Africa, has fewer than 100 
neurosurgeons (Warf et al., 2011).  
This situation begs the question: What is being done to remedy this problem of a 
paucity of neurosurgeons in Africa?  Because the use of ETV is still not widespread in 
Africa, it was not expected that many programs would be found in place with the goal of 
training surgeons in the endoscopic third ventriculostomy procedure.  However, it was 
hoped that any current strategies that may provide a replicable model for expanding the 
training, and ultimately use, of ETV would be identified.   
Method 
 To explore the answer to this question, A PubMed® search was performed for 
articles on neurosurgical management in patients with spina bifida. Articles were 
identified by searching for the terms “ETV and Africa and hydrocephalus.” They were 
then read and searched for mention of efforts to train locals in performing the ETV 
procedure. Articles were excluded if they did not refer to the management of 
hydrocephalus among individuals living with spina bifida in Africa. Articles meeting 
inclusion criteria were classified according to management method (shunt, ETV, 
ETV/Choroid plexus cauterization) and whether or not they mentioned efforts to train 
locals in this procedure. The countries reached by the training programs were identified 
and several characteristics of the models were explored. 
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Results 
A total of 47 articles were identified, of which 30 met inclusion criteria. Of these 
30, only five (0.17%) referred to efforts to train local medical professionals, including 
surgeons and nurses, on the use of ETVs. Of these five studies, only two gave more 
thorough descriptions of their efforts. One article described the efforts of the 
Neurosurgery Education and Development (NED) Foundation. The efforts of this 
educational programs reached seven African nations (Kenya, Tanzania, Ethiopia, 
Rwanda, Uganda, Sudan, and Zimbabwe). The NED Foundation trained 72 local 
surgeons, 122 nurses, and 49 volunteer neurosurgeons from those seven African nations 
through two mobile projects (Piquer et al., 2015). The training included techniques 
utilizing both ETV with and without CPC for hydrocephalus associated with varying 
conditions including, but not limited to, infection and myelomeningocele (Piquer et al., 
2015). It also underscored the need for efforts for long term follow-up (Piquer et al., 
2015). In an article by Laeke and his colleagues, the results of two studies, one performed 
predominantly by consultant surgeons and the other performed predominantly by 
residents, were compared and analyzed. Although the ETV failure rate in this study was 
higher than reported elsewhere, the failure rate decreased from the first to second study, 
probably reflecting a gain in collective experience (Laeke et al., 2017). It is hoped that 
this trend, in combination with the application of predictive models and increased access 
to imaging techniques, will allow for continued improvement and decreased failure rates 
(Laeke et al., 2017). 
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Discussion 
Like most literature reviews, this review had several limitations. One was the 
possibility that the exact search used did not pull in every single article relating to the 
question at hand. It is also likely that not all efforts in low-income countries are described 
in the literature, and that the lack of description of training efforts could in part be due to 
the fact that most of the articles were surgical in nature. However, overall it is still clear 
that there is a gap in the education of neurosurgeons in Africa. 
When looking to provide treatment for hydrocephalus in impoverished regions, it 
is essential that the resources and limitations of the setting are considered. That being 
said, it is important to note that although finding effective treatment for hydrocephalus 
and therefore improving spina bifida management in low-income countries is important, 
preventing these conditions in the first place would be the ideal alternative. As mentioned 
previously, folate supplementation in women of childbearing age has been shown to be 
beneficial in preventing the development of neural tube defects in their fetuses. However, 
although the regulatory agencies of more developed countries such as the United States 
have acted on this evidence by recommending folate supplementation as an important 
aspect of perinatal care, this is not something that is normally emphasized in developing 
countries. Warf and Campbell have suggested that the fact that neural tube defects are 
more common in East Africa compared to more developed regions is due in part to the 
lack of maternal and perinatal care, which would include measures such as folic acid 
supplementation (Warf and Campbell, 2008). One study reviewed the evidence for the 
impact of various community-based antenatal, intrapartum, and postnatal interventions on 
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neonatal health and survival in developing countries (Bhutta et al., 2005). Folate 
supplementation was identified as an important intervention to be included in a health 
program’s antenatal care package based on the evidence gathered (Bhutta et al., 2005). In 
countries with limited resources, preventing neural tube defects by implementing folate 
supplementation would ultimately be more cost effective than managing the effects of 
these conditions with various expensive surgical techniques. Therefore emphasizing 
preventative care should be a priority even over treatment by more expensive surgical 
salvage techniques.  
Although prevention is the preferred route for management of spina bifida, the 
reality is that right now many newborns in developing countries are affected by 
hydrocephalus. Until preventative measures are effectively implemented and their 
positive effects manifested in the population, hydrocephalus is still a problem that needs 
to be addressed. Although ETV has advantages over shunt placement in low-resource 
settings for the management of hydrocephalus, and efforts to train local surgeons in its 
use have been successful, very few institutions have developed training programs along 
with their outreach efforts. It is evident that training programs can strengthen 
collaboration among institutions from higher and lower income nations (Piquer et al., 
2015). However, this benefit will not be fully realized until current efforts are enlarged 
and new educational programs are developed to meet the growing need of individuals 
living with spina bifida-related hydrocephalus in Africa. 
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Future Work 
Because using ETV as a treatment method for spina bifida-related hydrocephalus 
is still a relatively new development, many areas regarding its use still need further study 
and development. The long-term effects it has on neurocognitive development compared 
to shunt placement will need further exploration. Methods for predicting success of ETV 
have been developed, but methods that are appropriate for settings where imaging 
equipment is limited should continue to be sought and developed. It is necessary that 
successful models for providing training on the ETV procedure be replicated and 
expanded to enable the spread of its implementation as a primary treatment for 
hydrocephalus in low-resource settings. Connections to allow for collaboration among 
institutions from higher and lower income nations should be established, as well as 
standard protocols for low-resource settings and follow-up and documentation strategies 
to enable the tracking of progress. Oftentimes patients were lost to follow-up before their 
progress could be duly noted, so this is a crucial area to be developed. The importance of 
community-based rehabilitation in the lives of patients with spina bifida has also been 
demonstrated. This is an essential aspect of providing care to this population, especially 
because of its role in neurocognitive outcomes for the patient. The support and care 
provided afterward can play just as much a role in the success of a procedure as the 
technique and performance of the procedure itself. Educating the community and families 
on how to provide that support is therefore also a vital undertaking.   
ETV is a treatment method that has the potential to revolutionize the management 
of spina bifida-related hydrocephalus in Africa. It is highly beneficial over 
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ventriculperitoneal shunts in that context in large part because it does not leave the 
patient with a lifetime dependency on hardware in the brain that could fail at any time. 
When paired with choroid plexus cauterization, it is even more effective as a treatment 
option for an even wider range of hydrocephalus etiologies. It therefore represents a key 
advancement in providing care to this population worldwide. However, its full potential 
to revolutionize treatment will not be seen until there are more efforts made in educating 
both local medical professionals on how to perform the ETV procedure itself, as well as 
the communities and families on how to provide care to these individuals beyond the 
walls of healthcare facilities.  If this can be achieved it will be a major advancement in 
the mission of providing care and the best possible quality of life to the spina bifida 
population across the globe. 
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